Nevrox is developing small molecule Protein Disulphide Isomerase (PDI) inhibitor to treat neurodegenerative diseases.

Scientific approach
Inhibition of PDI’s protein disulphide bond redox activity may relieve neuronal oxidative stress, which is considered a major factor in cell damage in neurodegenerative diseases.
Indications
Huntington’s disease, ALS
Team
Prof. Brent R. Stockwell, PhD, Inventor
Rachel Eren, PhD, CEO